Stamford, CT -- (SBWIRE) -- 01/28/2014 -- Jet Life Penny Stocks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Nuvilex Inc (OTCMKTS:NVLX), Solar3D Inc (OTCMKTS:SLTD), RXi Pharmaceuticals Corp (OTCMKTS:RXII), Alliqua Inc (OTCMKTS:ALQA)
Nuvilex Inc (OTCMKTS:NVLX) opened the session at $0.19, trading in a range of $0.18 - $0.21. The stock showed a positive performance of +14.29% in the last trading session from its previous close of $0.182 and closed at $0.208. The stock traded on a volume of 23.88 million shares and the average volume of the stock remained .59 million shares. Nuvilex, Inc. operates independently and through wholly owned subsidiaries. The Company is a biotechnology and life technology company with a specialty in living-cell encapsulation. It is focused on preparations for a new pancreatic cancer clinical trial through live-cell encapsulation of chemotherapeutic-converting cells.
For How Long NVLX will Fight for Profitability? Read This Trend Analysis report
Solar3D Inc (OTCMKTS:SLTD) traded 5.10 million shares in the last business day while the average volume of the stock remained 1.96 million shares. The stock showed a positive movement of +12.24% to end at $0.110. The 52 week range of the stock remained $0.01 - $0.14. Solar3D, Inc. is a development-stage company. The Company is engaged in the business of developing and marketing a three-dimensional (3-dimensional) solar cell technology to maximize the conversion of sunlight into electricity. The Company’s solar cell technology utilizes a 3-dimensional design to trap sunlight inside a photovoltaic structure where photons bounce around until they are converted into electrons. The wide-angle light collection feature on the cell surface allows for the collection of sunlight over a range of angles during the day.
For How Long SLTD’s Gloss will Attract Investors? Find out via this report
RXi Pharmaceuticals Corp (OTCMKTS:RXII) reported 127,141 shares were exchanged during the last trade, while the average volume is about 133,474 shares. The stock escalated +11.76% and finished the day at $4.75. RXi Pharmaceuticals Corporation (RXi) is a development-stage company. The Company is a biotechnology company focused on discovering, developing and commercializing therapies addressing medical needs using RNA interference (RNAi)-targeted technologies. As of July 12, 2012, RXi was focusing its internal therapeutic development efforts in fibrosis. RXI-109 is its RNAi product candidate, which is a dermal anti-scarring therapy that targets connective tissue growth factor (CTGF).
For How Long RXII’s Gloss will Attract Investors? Find out via this report
Alliqua Inc (OTCMKTS:ALQA) shares rose, +10.98 percent from its previous close of $8.20 to close at $9.10. Traded with volume of 110,022 shares in the prior session and the average volume of the stock remained 60,359 shares. Alliqua, Inc. (Alliqua), formerly HepaLife Technologies, Inc., biomedical company. Through AquaMed, the Company develops, manufactures and markets high water content, electron beam cross-linked, aqueous polymerhydrogels (gels) used for wound care, medical diagnostics, transdermal drug delivery and cosmetics. Through Alliqua Biomedical Inc., it focuses on the development of products for wound care dressings and a core transdermal delivery technology platform designed to deliver drugs and other beneficial ingredients through the skin.
Why Should Investors Buy ALQA After The Recent Gain? Just Go Here and Find Out
Jet Life Penny Stocks is always searching the market every day for massive penny stock runs before they happen so you don't have to. Our Penny Stock Newsletter also offers free Highly-Professional Grade stock charts and video charts from one of the most experienced and well-respected chartists in the penny stock industry.
Jet Life Penny Stocks is not a registered securities advisor. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides information on highlighted stocks via press releases, newsletters and company website, but this should not be construed as a recommendation to buy or sell. Please visit the company website for a more complete list of risks and disclosures.
Read full disclaimer at: http://www.jetlifepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)